Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shuyan (Sabrina) Wan"'
Autor:
Jue Hou, Rachel Zhao, Jessica Gronsbell, Yucong Lin, Clara-Lea Bonzel, Qingyi Zeng, Sinian Zhang, Brett K Beaulieu-Jones, Griffin M Weber, Thomas Jemielita, Shuyan Sabrina Wan, Chuan Hong, Tianrun Cai, Jun Wen, Vidul Ayakulangara Panickan, Kai-Li Liaw, Katherine Liao, Tianxi Cai
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e45662 (2023)
Although randomized controlled trials (RCTs) are the gold standard for establishing the efficacy and safety of a medical treatment, real-world evidence (RWE) generated from real-world data has been vital in postapproval monitoring and is being promot
Externí odkaz:
https://doaj.org/article/675e1c79c8b6440db4e28b056e8e8083
Autor:
Jue Hou, Rachel Zhao, Jessica Gronsbell, Yucong Lin, Clara-Lea Bonzel, Qingyi Zeng, Sinian Zhang, Brett K Beaulieu-Jones, Griffin M Weber, Thomas Jemielita, Shuyan Sabrina Wan, Chuan Hong, Tianrun Cai, Jun Wen, Vidul Ayakulangara Panickan, Kai-Li Liaw, Katherine Liao, Tianxi Cai
UNSTRUCTURED Although randomized controlled trials (RCTs) are the gold standard for establishing the efficacy and safety of a medical treatment, real-world evidence (RWE) generated from real-world data has been vital in postapproval monitoring and is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f545facc6d5425ca328127b5a1eea223
https://doi.org/10.2196/preprints.45662
https://doi.org/10.2196/preprints.45662
Autor:
Joseph F. Heyse, Shahrul Mt-Isa, Sheng Luo, Kan Li, Shuyan Sabrina Wan, William Wang, Paulette Ceesay, Shuai Sammy Yuan
Publikováno v:
Contemporary clinical trials. 67
Benefit-risk (BR) assessment is essential to ensure the best decisions are made for a medical product in the clinical development process, regulatory marketing authorization, post-market surveillance, and coverage and reimbursement decisions. One cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8e935cce3b89680e7a2c5c5994236f2
https://pubmed.ncbi.nlm.nih.gov/29505866
https://pubmed.ncbi.nlm.nih.gov/29505866
Autor:
Andrey Semenov, Thomas Powles, Patrick Wayne Cobb, Shuyan (Sabrina) Wan, Tian Zhang, David I. Quinn, Howard Gurney, Se Hoon Park, Francis Parnis, Jae-Lyun Lee, Toni K. Choueiri, Wayne Yen-Hwa Chang, Christian Heinrich Poehlein, Gurjyot K. Doshi
Publikováno v:
European Urology Supplements. 17:e1156-e1157
TPS712 Background: Most patients with intermediate- to high-risk advanced renal cell carcinoma (RCC) will progress within 3 years following nephrectomy. Novel treatments in the adjuvant setting are needed to prevent disease recurrence in these higher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24fdeb89e439375f4a61bf7f15a62a79
https://doi.org/10.1016/s1569-9056(18)31644-0
https://doi.org/10.1016/s1569-9056(18)31644-0
Autor:
Jens Bedke, Denis Soulières, Bohuslav Melichar, Raymond S. McDermott, Thomas Powles, Shuyan (Sabrina) Wan, Dmitry Nosov, Sergio J Azevedo, Viktor Stus, Rodolfo F. Perini, Brian I. Rini, Rustem Gafanov, Ihor Vynnychenko, Mei Chen, Satoshi Tamada, Robert E. Hawkins, Elizabeth R. Plimack, Delphine Borchiellini, Frédéric Pouliot, Michael B. Atkins
Publikováno v:
Journal of Clinical Oncology. 37:4500-4500
4500 Background: In KEYNOTE-426, pembro + axi significantly improved OS (HR 0.53, P < .0001), PFS (HR 0.69, P = .0001), and ORR (59.3% vs 35.7%, P < .0001) vs sunitinib and had manageable toxicity as first-line therapy for mRCC (NCT02853331). The pem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a342ee2436082048262f660a540cd62
https://doi.org/10.1200/jco.2019.37.15_suppl.4500
https://doi.org/10.1200/jco.2019.37.15_suppl.4500
Autor:
Jürgen E. Gschwend, Toni K. Choueiri, Thomas Powles, Shuyan (Sabrina) Wan, Tian Zhang, David I. Quinn, Christian Heinrich Poehlein
Publikováno v:
Annals of Oncology. 28:v327
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67a6305c2ee480ccfd055d1bbe82a719
https://doi.org/10.1093/annonc/mdx371.076
https://doi.org/10.1093/annonc/mdx371.076